lute tissue thromboplastin inhibition test than of the dilute Russell's viper venom test. Nonparametrically calculated reference ranges were wider than those determined by a parametric method, especially if confidence intervals are provided for both reference ranges in the group of 94 controls or in a subset of 40 subjects. The nonparametric technique utilizes all data for the calculation of reference ranges of such sample sizes no matter how wide the results are spread. There was no significant difference between the reference ranges of subsets and the whole group (p > 0.05) calculated by both statistical techniques.
Summary: Reference ranges for two well-recognized tests for the lupus anticoagulant were determined utilizing 98 healthy subjects. The purpose of the study was to compare the reference ranges for the dilute tissue thromboplastin inhibition test on this group of healthy subjects calculated by parametric and nonparametric statistical methods, and to compare these results with results obtained on subsets of 20 and 40 randomly selected individuals from the group of 98. The same procedures were followed for the dilute Russell's viper venom test. Results were recorded in seconds of clotting times and in ratios (subject/mean of that set or subset). Statistical analysis revealed Gaussian distribution of the results in the large group as well as in each subset for both tests. The results showed more variation between sets of the di-Causes for thromboembolic diseases and identification of circulating prothrombotic and thrombotic agents are top priorities for clinicians. The serious threats to the health and life of the patients posed by the diseases has made it mandatory that sensitive and specific laboratory tests be developed to assist the clinician in making a diagnosis. Laboratory tests that are based on phospholipid-dependent clotting times have been in use for the detection of the lupus anticoagulant for many years (1, 2) . The focus of our investigation is on the reference ranges (normal ranges) of two such tests: the dilute tissue throm-boplastin inhibition test (dTTI) and the dilute Russell's viper venom test (dRVVT). Our interest in the reference interval is prompted by the fact that published recommendations for the determination of this critical element of these laboratory tests are varied and ambiguous (1) (2) (3) (4) (5) (6) (7) (8) . Factors we have found to be most uncertain in the literature are recommendations for the number of healthy subjects required for the determination of the reference range and the manner in which data are analyzed. Information from textbooks of clinical laboratory diagnosis, textbooks on statistics, and scientific literature recommend that at least 40 and optimally 120 or more individual plasma samples from healthy subjects be tested to establish local reference ranges (8) (9) (10) (11) (12) (13) . Methods of statistical analysis for the production of reference intervals are discussed in the principal references (11, 13) . According to their recommendations, the interpercentile interval is the method of choice for the determination of the reference interval. It is common to define the reference interval as the central 95% interval bounded by the 2.5 and 97.5 percentiles (11, 13) . The interpercentile interval can be determined by both parametric and nonparametric statistical techniques; most authorities now recommend the nonparametric method of analysis because it makes no assumptions concerning the type of data distribution. It is easy and reliable whether data follow either Gaussian or non-Gaussian distribution (11, 13) . The smallest sample size to estimate the central 95% reference interval nonparametrically is 40 and the 70% or 90% confidence interval for 2.5% and 97.5% percentile points can be calculated from at least 75 and 120 reference values, accordingly (11, 13) .
It was the goal of this study to analyze the data we generated from the group of healthy controls to determine whether there was a Gaussian distribution of results in either or both of the tests (dTTL and dRVVT), and whether the reference ranges (normal ranges) were the same if calculated with both methods of statistical analysis. Results of both diagnostic tests of randomly selected subsets of whole group were assessed for Gaussian distribution as well, and were compared with the original group for statistical differences.
MATERIALS AND METHODS

Selection of Normal Subjects
A total of 98 randomly selected normal healthy volunteers of both sexes aged 18 to 30 years were evaluated for coagulation test normality by the prothrombin time (PT) and activated partial thromboplastin time (APTT). Ninety-four of the students have normal tests and were used in this study. There were initially 50 men and 48 women. Four men were excluded because of abnormal screening coagulation tests (outside 3 standard deviations [SD] from the mean normal value in PT or APTT tests).
Laboratory Studies
Blood sampling: Blood was drawn by clean venipuncture following a double syringe technique and placed into Vacutainer tubes containing 3.2% (0.105 M) trisodium citrate (Becton Dickinson Vacutainer Systems, Franklin Lakes, NJ) in the ratio of one part of citrate and nine parts of whole blood. The samples were then centrifuged at 2500g for 15 minutes to obtain platelet-poor plasma (PPP).
Assay Systems
The PT and APTT were determined on the analyzer ACL300 Plus (Beckman, Coulter, Miami, FL) by an automated method. For the PT, Dade Thromboplastin C Plus (Baxter, Miami, FL) reagent prepared from rabbit brain was used. For the APTT, Platelin L (Organon Teknika Corp, Durham, NC) reagent, containing micronized silica as activator and purified bovine phospholipids, was used.
The dTTI test was carried out by a semi-automated method on the Fibrometer (BBL, Microbiology Systems Becton Dickinson and Co, Cockeysville, NY) as per the procedure described by Schleider and associates (1) . Tissue thromboplastin reagent, Simplastin (Organon Teknika, Durham, NC) prepared from rabbit brain and lung tissue was diluted with 0.9% sodium chloride (Baxter Healthcare Corporation, Deerfield, IL) to 1:50 and 1:500 (2% and 0.2%, respectively). The dilutions were prepared as follows: a. Tube 1 (1:5): 0.4 mL of 0.9% NaCl+0.1 mL reconstituted Simplastin reagent. b. Tube 2 (1:50): 0.9 mL 0.9% NaCl+0.1 mL mixture from Tube 1. c. Tube 3 (1:500): 0.9 mL of 0.9% NaCl+0.1 mL mixture from Tube 2.
The diluted reagent was prewarmed at 370C for at least 10 minutes before testing. CaCl2 0.025 M (Organon Teknika Corp, Durham, NC) was also prewarmed at 37TC.
Procedure of dTTI Test 1. 0.1 mL plasma was mixed with 0.1 mL 1:50 dilution of Simplastin and incubated at 37°C for 5 minutes. 2. 0.1 mL of 0.025M CaCl2 was added and the Fibrometer started simultaneously. 3. Clotting time was recorded in seconds. 4. Steps 1 through 3 were repeated using 1:500 dilution of Simplastin. 5. The tests were performed in duplicate.
Procedure of dRW Test
The dRVV test was performed by a semiautomated procedure on the Fibrometer using a commercial test kit (DXVtest, American Diagnostica, Greenwich, CT). The reagent was reconstituted according to manufacturer's instructions and prewarmed for at least 10 minutes at 37°C.
0.2 mL of test plasma was pipetted into the
Fibrometer fibrocup and incubated for 2 minutes at 37°C. dTTI AND dRW REFERENCE RANGES 2. 0.2 mL of well-mixed prewarmed reagent was added to the test plasma and simultaneously the Fibrometer timer was started. 3. Clotting time was recorded in seconds. 4. The tests were performed in duplicate.
Antiphospholipid antibodies were determined utilizing Asserachrom APA (Diagnostica Stago, France) according to the manufacturer's instructions.
Data Analysis and Statistical Methods
Results of diagnostic tests were tabulated as clotting times in seconds (average of duplicate results). Histograms for the results in seconds as well as for the ratios were computer generated, and the normality of the distribution of data was analyzed using GraphPad Prism Software (GraphPad Software, Inc, San Diego).The mean and standard deviation were calculated for each test system. Subsequently ratios of individual clotting times to the study group mean value were determined. The 70% confidence intervals for both parametric reference limits were established. Results of clotting tests were analyzed by the nonparametric method as well. Ranking from the lowest value to the highest was performed using Microsoft Excel 97 and the manual method was utilized to calculate 2.5% to 97.5% reference limits and their 70% confidence intervals. For the detection of outliers, Grubb's test was used. Differences between random subsets and whole study group were assessed by two-way ANOVA for the parametric method and the Kruskal-Wallis test for the nonparametic method using GraphPad Prism Software.
RESULTS
The results of the clotting tests expressed as reference ranges (mean +2SD) in seconds and as the mean ±2SD of the ratios (subject/whole group mean) are shown in Table 1 . In this table, the total of 94 subjects was the remainder after excluding four outliers, two on PT, and two on the APTT tests. Only 93 of the 94 could be analyzed on the dTTI 1:50 dilution due to lack of sufficient sample and only 92 on the DWtest for the same reason. Numbers of subjects whose values were outside 2SD and 3SD are shown for each test system. Comparative results of parametric and nonparametric methods of statistical analysis for calculation of central 95% reference ranges of these tests and 70% confidence interval for its lower and upper reference limits of the whole group are shown in Table 2 . Similarly, reference ranges and confidence intervals for both reference limits are calculated for the whole group of students, excluding two possible outliers for the dTTI and one for the dRVVT (i.e., values outside mean ±3SD and positive Grubb's test and one sample positive for antiphospholipid antibodies in Asserachrom APA assay) are presented in Table 3 .
Random subsets of ten men and ten women constituting a group of 20, and a similarly constituted group of evenly divided 40 men and women were separately analyzed with the same methods as those for the entire group. The results are shown for reference ranges as clotting times in seconds in Table 4 comparing parametric and nonparametric methods. Reference ranges for clotting time ratios (subject/subgroup mean) are presented in Table 5 .
Histograms of the test results of various study groups (Figs. 1-10) show Gaussian distribution confirmed by statistical tests utilizing the GraphPad Prism computer program.
The results are based on a final population of 94 for whom adequate sample was available for analysis and in 93 or 92 where it was not. Ninety-nine percent of the population fell within 3 SD of the mean in the dRVVT and in the 1:500 Tables 2, 3 ).
Even the small subset of 20 (ten men, ten women) and similarly of 40 had Gaussian distribution (Figs. 7-10; Tables 4, 5 ) and there was no significant difference between the reference ranges of these subsets and the whole group (p > 0.05) calculated by both statistical methods. The results showed slightly more variation between sets of the dTTI test than of the dRVVT test. In subset 40B of the dTTI test reference range calculated nonparametrically is much wider than that determined parametrically because the nonparametric method utilizes all 40 test values (no matter how widely spread they are) for the calculation of the reference interval. We have confirmed that the dTTI and dRVVT tests are quite similar when assessing a healthy population.
DISCUSSION
Reports in the medical literature vary greatly in their methods for the determination of refer- (6, 14) . Methods of statistical analysis were usually not stated or vaguely described. This analysis reasonably represents what is to be expected in a healthy 18to 97.5% percentile points are provided. This is more pronounced for dTTI. These results are in agreement with data from the literature, which states that the parametric estimates of percentiles are theoretically more precise (narrower confidence intervals) than those obtained by nonparametric method, especially with small sample sizes (11, 13) . Our and other's data point to the crucial need of the correct identification and handling of possible outliers in control groups as large as 100 healthy subjects because normal range estima-tion by the nonparametric method entirely depends on the one or two lowest or highest values. Samples from subclinically ill patients, and technical or clerical errors can considerably distort final normal range estimates. Nonparametric methods based on the extremes of ranked data are quite sensitive to overzealous discarding of the test results of normal persons, which reflect extreme biologic variation (11) . Bearing in mind heterogeneity of lupus anticoagulant and other antiphospholipid antibodies, this important area of uncertainty should not be forgotten when one FIGS. 1-6. Frequency distribution of dTTI 1:50, dTTI 1:500, and dRVV as clotting in seconds as well as in ratio in whole study population vs Gaussian (theoretical mean). We believe that when the distribution is Gaussian, a parametric method of statistical analysis is preferred. With this method one can utilize mean and standard deviation to define reference ranges. When it is not Gaussian, it is not appropriate to describe reference ranges in terms of mean and standard deviation and the nonparametric statistical method based on ranks should be used. In either case it is desirable to calculate defined confidence interval for both reference limits. From our study we note that there was not a significant difference between the reference ranges of the random subsets of 20 or 40 and the group of 94 calculated by both statistical tech- niques. But it must be emphasized that 70% or 90% confidence interval can be calculated only from sample sizes as large as 75 and 120 subjects, respectively utilizing the nonparametric method. The more subjects there are, the more reliable the reference ranges will be, with a practical number being 120. One should strive to obtain as many values as possible, especially if great biologic variation is anticipated (11) .
It has been suggested that the problem of determining proper reference ranges, might be solved by having them determined by a regional laboratory. This could be helpful in terms of the same group of healthy controls being used to develop reference ranges for a number of specific tests, but it must be understood that when the test is then performed on patient samples in a local laboratory, the same reagents and instrumentation as used in the regional laboratory would be required. dTTI AND dRVV REFERENCE RANGES Because our population was too restricted in age to represent the entire adult age range a more broadly based healthy control group might give different results. We recognize that our specimen handling was less than optimal for a study involving subjects being tested for the presence or absence of the lupus anticoagulant by virtue of the centrifugation step being insufficient to remove a specified amount of platelets (15) . This however is not critical to the purpose of our study because we were not using this group of normal subjects to diagnose cases of lupus anticoagulant, although in establishment of a reference range for a clinical laboratory, control samples should be processed in the same manner as patient samples. The reference ranges we determined do not represent intervals that can or should be used in other laboratories for diagnosing lupus anticoagulant.
Because it has been shown that some very dilute lupus anticoagulants may fall within the reference range (false-negative results), we are reminded that the reference range should be very accurate. Patients with low-normal values may present with a high-normal value when they develop lupus anticoagulant, escaping detection in our test systems. Modified test systems now have been devised to detect false-negative results (16, 17) .
The utilization of published reference ranges for a given test can result in unacceptable inaccuracies in patient testing. Due to all the variables that can influence the results (including instrumentation), using the reference range from published data is unacceptable (18, 19) . Each laboratory should determine its own reference ranges by methods we suggest in this article, and as suggested by others.
